DLA Piper
Client SatisfactionDLA Piper’s healthcare and life sciences practice spans the sector, with experience in corporate, regulatory, public procurement, privacy, IP, competition and litigation. The firm advises major players in the industry, including national and multinational pharmaceutical corporations, on domestic and cross-border matters. Roberto Valenti is the head of the department at the firm; he advises on IP litigation and commercial matters in the life science sectors, with particular expertise on matters involving medical devices. Marco de Morpurgo focuses on the EU and national regulation of pharmaceuticals, biotech and medical devices. Raffaella Quintana (compliance and criminal law) and Gualtiero Dragotti (IP) can bring their considerable talents to this sector.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘The team is well prepared, open and available to specific requests. They are also skilled at managing discussions and talented. ’
‘Empathetic and personalized customer management.’
‘Acumen, sophistication, and the ability to interpret not only the laws but also environmental situations.’
‘Roberto Valenti is a very open leader, capable of managing discussions and finding the right compromise on discussed issues.’
‘Strong work ethic. Adaptable. Problem solving and analytical thinking.’
‘Marco de Morpurgo is a go-to at DLA. He is an extremely reliable partner. He ensures the right lawyers in DLA's broad network.’
‘The team is very competent and has a great deal of experience in the matter that interests my company.’
Key clients
- Pfizer Inc.
- GlaxoSmithKline
- Iovance Biotherapeutics
- Vertex Pharmaceuticals
- Essity
- Sifi
- Menarini Group
- Medtronic
- Reckitt Benkiser
- GE Healthcare
Work highlights
- Advised Pfizer Inc. with regard to the agreement for the supply of their Covid-19 Vaccine across Europe.
- Assisting Medtronic Inc. in a patent dispute among European leading manufacturers and suppliers of a range of medical devices for respiratory support, in connection with the alleged infringement of two European patents referred to devices for oxygen administration in the intensive therapy.
- Assisted Sifi S.p.A. in the implementation of the license agreement regarding SIFI IP (including a patent which is crucial for the manufacture of the product) for the manufacturing and marketing of intra-ocular lenses and other surgical devices for the treatment of eye diseases in Greater China.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Marco de Morpurgo
DLA PiperPractice head
The lawyer(s) leading their teams.
Roberto Valenti